Related Articles
Uncommon gastrointestinal bleeding during targeted therapy for advanced renal cell carcinoma: A report of four cases
Efficacy and safety of sorafenib in advanced renal cell carcinoma patients: Results from a long-term study
5‑fluorouracil enhances the antitumor effect of sorafenib and sunitinib in a xenograft model of human renal cell carcinoma
A combination of sorafenib and radiotherapy reduces NF‑κB activity and growth of hepatocellular carcinoma in an orthotopic mouse model
Combination of the ERK inhibitor AZD6244 and low-dose sorafenib in a xenograft model of human renal cell carcinoma